The federal indictment says four Southern California hospice companies submitted approximately $27.7 million in allegedly false claims and received about 97 percent of that amount before authorities intervened and charged three defendants.
WASHINGTON, D.C., August 23, 2026 — Medicare paid approximately $26.908 million to four hospice companies allegedly controlled by Oren David Shachar after those businesses submitted roughly $27.731 million in false claims, according to a sweeping federal indictment filed in Los Angeles.
The extraordinary payment ratio means the federal insurance program allegedly approved about 97 percent of the money the hospices claimed, leaving only about $823,000 unpaid while millions of public dollars flowed through an operation prosecutors describe as fraudulent.
Federal authorities allege that Shachar and his associates enrolled people who were not terminally ill, paid cash and gifts to keep beneficiaries participating, and exploited personal information belonging to deceased Medicare recipients to support backdated hospice records.
Shachar, Abraham Shin, and Jeannie Choi face multiple federal charges arising from the alleged operation, but every accusation remains unproven, and each defendant is presumed innocent unless prosecutors establish guilt beyond a reasonable doubt in court.
Medicare allegedly paid nearly every dollar billed
The approximately $26.9 million payment total gives the Oren Shachar hospice fraud case unusual significance because it measures alleged losses Medicare has already sustained, rather than merely describing ambitious invoices that government reviewers rejected before releasing taxpayer funds.
Viewed another way, the alleged claims produced about 97 cents in Medicare payments for every dollar billed, a conversion rate that may matter as investigators, defense lawyers, and compliance specialists examine how the submissions passed administrative screening.
The 16-count federal indictment alleges that the claims covered hospice services that were medically unnecessary, ineligible for reimbursement, not provided as represented, or obtained through illegal kickbacks and bribes between February 2021 and March 2026.
Although the difference between amounts billed and paid was approximately $823,000, that unpaid portion represents only about three percent of the overall submission total, underscoring how effectively the alleged network converted questionable billing into federal reimbursements before the criminal case surfaced.
Four hospices formed the alleged billing network
Prosecutors identify Gentle Touch Hospice Care in Valley Glen, Oxford Hospice Care in Montclair, Art of Hospice in Encino, and Holly Trinity Hospice in Glendale as the four outpatient companies Shachar allegedly owned, controlled, or operated.
Court filings trace Shachar’s alleged involvement with Art of Hospice to approximately October 2019, Oxford Hospice to approximately December 2020, Gentle Touch Hospice to approximately February 2021, and Holly Trinity Hospice to approximately April 2023.
That expanding corporate footprint allegedly allowed the operation to distribute enrollments and Medicare claims across several providers, potentially making activity appear less concentrated than it would have looked if every beneficiary and payment had passed through one hospice.
The indictment collectively calls those businesses the Shachar Hospices, while prosecutors contend that their billing privileges became the financial infrastructure through which beneficiary information, clinical documentation, electronic claims, and federal payments were repeatedly connected.
Why Medicare hospice eligibility matters
Medicare hospice coverage is designed for a beneficiary whose physician certifies that the person is terminally ill, generally meaning the individual is expected to live six months or less if the underlying illness follows its ordinary course.
An eligible patient must also elect palliative hospice care and acknowledge that Medicare will generally stop covering treatment intended to cure the terminal condition, making informed consent an essential safeguard rather than an administrative formality.
Covered services can include nursing care, pain and symptom medication, medical equipment, social services, dietary counseling, therapy, and spiritual support, all structured around comfort and dignity when curative treatment is no longer the governing objective.
Because hospice enrollment changes a beneficiary’s access to other Medicare-covered treatment, prosecutors portray any alleged misrepresentation of eligibility as more than financial misconduct, since an improper election can alter decisions involving primary physicians, specialists, medication, and continuing curative care.
Prosecutors allege beneficiaries were misled and induced
The indictment alleges that Shachar personally met Medicare beneficiaries whom he knew were not terminally ill and described his services as improving quality of life, while allegedly obscuring the program’s defining role as end-of-life care.
Prosecutors further contend that prospective and enrolled beneficiaries were not fully told that physicians had to certify terminal illness or that hospice participation could restrict Medicare benefits for treatment furnished by primary-care doctors and other providers.
To secure continued enrollment, Shachar allegedly paid beneficiaries as much as $400 monthly in cash and supplied groceries, alcohol, personal-care products, medical equipment, televisions, massages, furniture, and reclining chairs as additional inducements to continue participating.
The government also claims beneficiaries were offered between $100 and $200 for every additional patient they referred, creating an alleged recruitment chain in which people receiving payments could become sources for still more reimbursable hospice enrollments.
Patient marketers allegedly received recurring referral payments
According to prosecutors, Shachar paid marketers and recruiters, including Shin and Choi, for Medicare beneficiary referrals, sometimes providing about $700 for each living patient each month the hospice continued billing the federal program.
Prosecutors say recurring compensation made a beneficiary more valuable the longer enrollment continued, which helps explain allegations that cash and practical household benefits were used to discourage participants from leaving the hospices.
The indictment separately identifies two alleged $300 referral payments, one offered and paid to Choi in September 2025 and another offered and paid to Shin in January 2026, as specific Anti-Kickback Statute counts.
Federal anti-kickback rules are central to Medicare integrity because medical referrals should reflect patient needs and independent clinical judgment, not hidden compensation arrangements that reward recruiters based on enrollment volume or billing duration.
Deceased beneficiaries allegedly became billing instruments
The most disturbing allegations concern deceased Medicare beneficiaries whose names, Social Security numbers, birth dates, Medicare identifiers, death information, physicians, and next-of-kin details were allegedly acquired and repurposed for fabricated hospice enrollment records.
Prosecutors claim Choi accessed identifying information through her employment at a Los Angeles-area funeral home, then transmitted documents and personal details through text messages and WhatsApp communications allegedly involving Shin and Shachar directly.
The indictment alleges that Shachar paid between $1,000 and $3,000 for each deceased beneficiary referral ultimately enrolled, transforming information gathered around a family’s bereavement into an alleged mechanism for claiming federal hospice reimbursements.
The allegations illustrate why identity-crime prevention and awareness extend beyond compromised credit cards or financial accounts, because stolen medical identifiers can be combined with death records, health histories, and government benefit numbers to support sophisticated institutional fraud.
Backdated records allegedly concealed post-death enrollment
After identifying a deceased person who had held Medicare coverage, Shachar or associates allegedly contacted surviving relatives, obtained additional health information, and requested records from hospital visits preceding the person’s recorded date of death.
Prosecutors claim nurses, a physician identified without a public name, and other participants were directed to create false electronic records stating that the deceased beneficiary had been evaluated while alive and medically certified as terminally ill.
Those records were allegedly backdated so the hospices could claim services began before death, creating the appearance of legitimate end-of-life care even though the government says the underlying enrollment occurred afterward.
The case consequently presents an especially stark form of alleged identity misuse, closely resembling conduct discussed in Amicus International’s analysis of unlawful identity acquisition, where assuming or exploiting a deceased person’s identity is distinguished from lawful, government-recognized identity change.
Rules allegedly targeted Medicare’s fraud indicators
The indictment says Shachar imposed conditions for deceased referrals, allegedly favoring people who died at home, died within five days after marketer contact, and had not already received hospice services from another provider when death occurred.
Prosecutors contend those restrictions were intended to reduce scrutiny, while accurate death dates and times allegedly helped participants prepare internally consistent records and arrange meetings with relatives for hospice paperwork after the beneficiary had already died.
The government further alleges that deceased enrollments helped disguise a high live-discharge rate, an indicator that can emerge when many supposed hospice patients survive or leave care because they were never terminally ill when enrolled.
Those enrollments also allegedly helped offset Medicare’s annual per-patient spending limit, demonstrating how prosecutors believe clinical records, mortality patterns, billing thresholds, and corporate accounts were coordinated rather than manipulated through isolated paperwork errors.
The payment ratio raises difficult oversight questions
The approximately 97 percent payment rate does not independently establish criminal intent, because Medicare processes vast numbers of claims through standardized systems, but it highlights the challenge of detecting fabricated eligibility when submitted records appear internally complete.
Claims ordinarily contain beneficiary identifiers, service dates, treatment descriptions, and attending-provider information, while participating providers agree that electronic submissions will be truthful, accurate, and compliant with federal laws governing Medicare reimbursement and referrals.
When supporting documentation is itself allegedly manufactured, however, automated systems may encounter a coherent package of names, dates, certifications, and billing codes that appears legitimate until claims are compared with death data, medical histories, referral relationships, and communications.
That apparent vulnerability helps explain why the alleged $27.731 million submission generated about $26.908 million in payments, rather than being stopped early by a single inconsistency or an obviously impossible billing pattern.
Selected claims anchor the broader conspiracy allegation
Counts two through nine identify eight particular claims allegedly submitted from August 2023 through November 2025, using beneficiary initials and amounts ranging from several hundred dollars for purported short periods to more than $6,000 for other services.
Those selected transactions do not represent the entire alleged loss, but they give prosecutors specific executions of the wider scheme to present through billing records, witness testimony, enrollment documents, electronic communications, and evidence concerning individual beneficiaries.
Counts ten through twelve add aggravated identity-theft allegations tied to three deceased beneficiaries whose names, Social Security numbers, and Medicare identification numbers were allegedly used without lawful authority in connection with specified health care fraud counts.
Because aggravated identity theft can carry a mandatory consecutive prison term after conviction, those counts materially increase the criminal exposure beyond penalties potentially associated with conspiracy, health care fraud, kickbacks, and financial transactions involving alleged proceeds.
Luxury spending enters the government’s financial narrative
Prosecutors allege that a $15,000 transfer from Holly Trinity Hospice’s JPMorgan Chase account was wired in September 2024 as partial payment toward a lease-to-own down payment for a Rolls-Royce Phantom luxury automobile.
Count thirteen characterizes that transaction as involving criminally derived property worth more than $10,000, connecting the alleged movement of Medicare reimbursements to a recognizable luxury asset rather than leaving the financial case at an abstract accounting level.
The Wall Street Journal’s reporting on the national crackdown likewise highlighted the Shachar allegations, including the nearly $27.7 million in claims, the approximately $26.9 million Medicare payment, and the alleged use of deceased beneficiaries’ information.
Federal forfeiture allegations seek property constituting or derived from proceeds traceable to charged offenses, while substitute-asset provisions could apply following a conviction if targeted property cannot be located, has been transferred, or was commingled.
Sixteen counts create several paths to potential liability
The indictment charges conspiracy to commit health care fraud, eight substantive health care fraud counts, three aggravated identity theft counts, one monetary transaction involving alleged criminal proceeds, two kickback-payment counts, and one count involving beneficiary identifiers.
Count sixteen specifically alleges that Shachar sold or arranged the sale of nine Medicare beneficiary identification numbers to a physician for $12,500 in March 2025, adding another alleged revenue stream involving protected health identifiers.
The government must prove the required elements of each count against the defendant or defendants named, including knowledge and intent where applicable, while the defense may challenge records, witnesses, attribution, financial tracing, and the interpretation of conduct.
An indictment records a grand jury’s accusation and permits a prosecution to proceed, but it is neither trial evidence nor a verdict, and it cannot lawfully substitute for proof tested through the adversarial process.
Shin and Choi face allegations alongside Shachar
Shin is described as a patient marketer who allegedly joined the conspiracy no later than March 2025, while Choi allegedly participated beginning no later than May 2025 and continuing through at least November that year.
Their alleged roles center on referrals and deceased beneficiaries’ identifying information, yet criminal responsibility must still be determined individually because participation, knowledge, communications, payments, and conduct can differ substantially among people charged in one indictment.
Federal authorities arrested Shachar and Shin on June 18, 2026, and the Justice Department said both appeared and were arraigned that day before a federal magistrate judge ordered their release on bond pending further proceedings.
Choi was arrested several days later, while prosecutors announced the case publicly as one component of a much larger coordinated national enforcement operation targeting alleged fraud across government-funded health programs and controlled-substance prescribing.
The case formed part of a historic national takedown
The Justice Department announced charges against 455 defendants, including 90 physicians and other licensed professionals, in cases alleging more than $6.5 billion in fraudulent claims across 56 federal districts and 45 states and territories.
Authorities reported seizing more than $182 million in cash, vehicles, jewelry, and other assets, while administrative actions included payment suspensions, billing-privilege revocations, provider exclusions, civil settlements, and demands for money stopped before disbursement.
Within Southern California, federal prosecutors charged ten defendants in cases spanning alleged Medicare hospice fraud, Medi-Cal prescription billing, unnecessary laboratory testing, falsified psychiatric reporting, and illegitimate controlled-substance prescribing among licensed medical professionals across the region.
The Shachar case stands apart within that regional group because its alleged conduct combines questionable hospice eligibility, recurring kickbacks, post-death identity exploitation, fabricated medical documentation, high Medicare payouts, and luxury-asset spending within one prosecution.
Hospice fraud can harm patients beyond financial losses
Every dollar allegedly diverted from Medicare matters to taxpayers, yet improper hospice enrollment can also create direct clinical consequences when beneficiaries misunderstand that electing palliative care may limit coverage for treatment intended to cure their terminal condition.
Patients recruited with cash, groceries, furniture, or other benefits may be especially vulnerable to incomplete explanations, particularly when financial hardship, disability, advanced age, limited health literacy, or trust in medical intermediaries influences their decisions.
Families of deceased beneficiaries face a different injury when a loved one’s identity is allegedly used after death, because the resulting records can distort medical history, complicate benefit files, and turn private bereavement information into evidence within litigation.
Legitimate hospice providers also carry reputational costs when sensational allegations create public suspicion, even though compliant organizations deliver essential pain management, counseling, nursing support, and dignity to eligible patients and their families every day.
Data integration may determine whether future claims are stopped
The allegations suggest that faster comparison of hospice enrollment dates with verified death records could reveal impossible timelines, while analysis of unusually high referral payments or repeated marketer relationships might expose financial incentives hidden beneath otherwise plausible claims.
Reviewers could also examine live-discharge patterns, beneficiary complaints, recurring physician certifications, geographic anomalies, overlapping provider ownership, unusual changes in patient census, and suspicious concentrations of enrollments occurring immediately before officially reported beneficiary deaths.
No single indicator proves fraud, because legitimate hospices can show unusual patient patterns, but combining multiple anomalies lets investigators prioritize claims for human review before questionable payments accumulate across several companies and many years.
The $26.9 million allegedly paid in this case therefore illustrates the difference between recovering money after prosecution and preventing loss through earlier detection, stronger identity controls, reliable death-data matching, and careful verification of terminal-illness certifications.
What the indictment means for hospice compliance
Hospice owners and administrators should treat beneficiary consent, clinical eligibility, referral compensation, medical-record integrity, ownership disclosures, and billing accuracy as interconnected obligations, because weakness in one area can expose the entire organization to scrutiny.
Clinical staff should never backdate evaluations, certify conditions they did not assess, or sign documents whose factual basis they cannot verify, while marketers must understand that compensation tied to federally reimbursed referrals can create profound criminal and regulatory risks.
Organizations also need controls preventing funeral-home information, death certificates, Medicare identifiers, and next-of-kin details from being repurposed outside authorized functions, particularly when vendors or marketers can access multiple sources of sensitive personal data.
Independent audits should follow the money as well as the medical chart, comparing referral payments, beneficiary incentives, company accounts, luxury purchases, discharge patterns, and electronic communications with the underlying services represented to Medicare reviewers.
The next stage belongs to the federal court
When prosecutors announced the arrests, the Justice Department said Shachar and Shin were scheduled for trial on August 11, although court calendars and pretrial schedules can change through later judicial orders, motions, continuances, or case developments.
Future proceedings may address discovery, expert testimony, admissibility of electronic messages, authentication of medical records, financial tracing, beneficiary eligibility, alleged kickback arrangements, forfeiture claims, and whether separate evidence proves each charged defendant’s intent.
The government’s $26.908 million payment figure will remain central because it expresses alleged harm in actual Medicare disbursements, while the defense retains every right to contest whether claims were false, who caused them, and what participants understood.
Until a jury returns a verdict or defendants resolve charges through another lawful process, descriptions of the Oren Shachar hospice fraud scheme must remain explicitly framed as allegations supported by prosecutors’ filings, not established historical facts.
A 97 percent payout becomes the case’s defining number
The central financial allegation is ultimately straightforward but consequential: four hospices allegedly billed Medicare approximately $27.731 million, and the federal program paid approximately $26.908 million for claims prosecutors say should not have been reimbursed as submitted.
Behind that figure lies a far more complicated evidentiary narrative involving terminal-illness certifications, patient consent, cash incentives, marketer payments, deceased identities, backdated records, electronic communications, corporate accounts, and an alleged luxury-vehicle transaction using Medicare proceeds.
For taxpayers, the case demonstrates how quickly apparently complete medical claims can become major public losses, while for patients and families, it shows why hospice decisions require truthful explanations, authentic records, and uncompromised clinical judgment.
For the defendants, however, the decisive facts will be those proven under federal evidentiary rules, because even a detailed indictment and striking payment ratio cannot eliminate the constitutional presumption of innocence or reduce the prosecution’s burden.
